Jon Jin Kim

发表

HLA sensitisation: can it be prevented?

Lesley Rees, L. Rees, Jon Jin Kim, 2014, Pediatric Nephrology.

Epidemiology of chronic kidney disease in children

K. V. van Stralen, Jon Jin Kim, J. Harambat, 2011, Pediatric Nephrology.

Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies

S. Marks, Jon Jin Kim, Lindsay S. Keir, 2012, Drug design, development and therapy.

Complement-mediated renal diseases after kidney transplantation - current diagnostic and therapeutic options in de novo and recurrent diseases

Jon Jin Kim, I. Shaheen, A. Halawa, 2018, World journal of transplantation.

Rabbit anti-thymocyte globulin (rATG) versus IL-2 receptor antagonist induction therapies in tacrolimus-based immunosuppression era: a meta-analysis

R. Pararajasingam, Jon Jin Kim, M. E. Kossi, 2020, International Urology and Nephrology.

The demographic characteristics of children with chronic kidney disease stages 3–5 in South East England over a 5-year period

M. Sinha, Jon Jin Kim, C. Booth, 2013, Archives of Disease in Childhood.

Outcomes of paediatric kidney transplant recipients using the updated 2013/2017 Banff histopathological classification for antibody-mediated rejection

N. Sebire, S. Marks, N. Mamode, 2021, Pediatric Nephrology.

Experience of the first 6 years of pediatric kidney transplantation in Indonesia: A multicenter retrospective study

Jon Jin Kim, I. Wahyudi, G. Situmorang, 2020, Pediatric transplantation.

Immunoadsorption for haemolytic uraemic syndrome

Jon Jin Kim, 2011, The Lancet.

Thrombotic microangiopathy after renal transplantation: Current insights in de novo and recurrent disease

Jon Jin Kim, A. Halawa, Ajay K. Sharma, 2018, World journal of transplantation.

Does HLA matching matter in the modern era of renal transplantation?

S. Fuggle, S. Marks, Jon Jin Kim, 2019, Pediatric Nephrology.

Emulation of the control cohort of a randomized controlled trial in pediatric kidney transplantation with Real-World Data from the CERTAIN Registry

L. Weber, B. Tönshoff, D. Haffner, 2022, Pediatric Nephrology.

Long-term outcomes of children after solid organ transplantation

S. Marks, Jon Jin Kim, 2014, Clinics.

Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations

Jon Jin Kim, T. Goodship, C. Inward, 2011, Pediatric Nephrology.

Nephrotic syndrome in infancy can spontaneously resolve

N. Sebire, D. Milford, N. Moghal, 2011, Pediatric Nephrology.

Washing red cells after leucodepletion does not decrease human leukocyte antigen sensitization risk in patients with chronic kidney disease

R. Vaughan, R. Cardigan, R. Liesner, 2014, Pediatric Nephrology.

Implication of interleukin-2 receptor antibody induction therapy in standard risk renal transplant in the tacrolimus era: a meta-analysis

Jon Jin Kim, I. Shaheen, A. Halawa, 2019, Clinical kidney journal.

Molecular HLA mismatching for prediction of primary humoral alloimmunity and graft function deterioration in paediatric kidney transplantation

L. Weber, B. Tönshoff, V. Kosmoliaptsis, 2023, Frontiers in Immunology.

Defining a threshold for tacrolimus intra-patient variability associated with late acute cellular rejection in paediatric kidney transplant recipients

Nor Mohamad, Z. Hodi, Jon Jin Kim, 2019, Pediatric Nephrology.

Donor Specific Antibodies are a Major Contributor of Graft Loss in Paediatric Renal Transplant Recipients

R. Vaughan, N. Sebire, Jon Jin Kim, 2013 .

QUESTION 2. Does nephrocalcinosis in ex-premature babies cause long-term renal problems?

Jon Jin Kim, S. Amin, 2009, Archives of Disease in Childhood.

Improve in-depth immunological risk assessment to optimize genetic-compatibility and clinical outcomes in child and adolescent recipients of parental donor kidney transplants: protocol for the INCEPTION study

A. Teixeira-Pinto, L. D'Orsogna, F. Claas, 2021, BMC Nephrology.

Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies

R. Vaughan, N. Sebire, S. Marks, 2017, Pediatric Nephrology.

Recurrence, Rejection or Chronic Kidney Allograft Dysfunctions; Solving the Conundrum of Allograft Dysfunction

R. Pararajasingam, R. Oluyombo, Jon Jin Kim, 2019 .

The UK kidney donor risk index poorly predicts long-term transplant survival in paediatric kidney transplant recipients

V. Kosmoliaptsis, S. Marks, Jon Jin Kim, 2023, Frontiers in Immunology.

Increasing SARS-CoV-2 seroprevalence among UK pediatric patients on dialysis and kidney transplantation between January 2020 and August 2021

P. Tighe, A. Tarr, W. Irving, 2023, Pediatric Nephrology.

Safety, Tolerability, and Pharmacokinetics of Oral Ferric Maltol in Children With Iron Deficiency: Phase 1 Study

Jon Jin Kim, B. Vadamalayan, M. Auth, 2021, JPGN reports.

The clinical spectrum of hemolytic uremic syndrome secondary to complement factor H autoantibodies.

M. McCulloch, A. Waters, S. Marks, 2015, Clinical nephrology.

Eculizumab in atypical haemolytic–uraemic syndrome allows cessation of plasma exchange and dialysis

Jon Jin Kim, C. Reid, S. Waller, 2012, Clinical kidney journal.

Demographics of children with chronic kidney disease in the UK

Jon Jin Kim, S. Waller, P. Rasmussen, 2013 .

The Clinical Spectrum of De Novo Donor‐Specific Antibodies in Pediatric Renal Transplant Recipients

R. Vaughan, N. Sebire, S. Marks, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies

S. Marks, Jon Jin Kim, Lindsay S. Keir, 2012, Drug design, development and therapy.